220 related articles for article (PubMed ID: 21627711)
1. Topical prolyl hydroxylase domain-2 silencing improves diabetic murine wound closure.
Wetterau M; George F; Weinstein A; Nguyen PD; Tutela JP; Knobel D; Cohen Ba O; Warren SM; Saadeh PB
Wound Repair Regen; 2011; 19(4):481-6. PubMed ID: 21627711
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene.
Wu S; Nishiyama N; Kano MR; Morishita Y; Miyazono K; Itaka K; Chung UI; Kataoka K
Mol Ther; 2008 Jul; 16(7):1227-34. PubMed ID: 18500250
[TBL] [Abstract][Full Text] [Related]
3. Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.
Zhang X; Yan X; Cheng L; Dai J; Wang C; Han P; Chai Y
PLoS One; 2013; 8(12):e84548. PubMed ID: 24376825
[TBL] [Abstract][Full Text] [Related]
4. Acceleration of Diabetic Wound Healing with PHD2- and miR-210-Targeting Oligonucleotides.
Dallas A; Trotsyuk A; Ilves H; Bonham CA; Rodrigues M; Engel K; Barrera JA; Kosaric N; Stern-Buchbinder ZA; White A; Mandell KJ; Hammond PT; Mansbridge J; Jayasena S; Gurtner GC; Johnston BH
Tissue Eng Part A; 2019 Jan; 25(1-2):44-54. PubMed ID: 29644938
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
[TBL] [Abstract][Full Text] [Related]
6. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.
Chen JX; Stinnett A
Diabetes; 2008 Dec; 57(12):3335-43. PubMed ID: 18835934
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent impairment of HIF-1alpha expression in diabetic mice: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells.
Liu L; Marti GP; Wei X; Zhang X; Zhang H; Liu YV; Nastai M; Semenza GL; Harmon JW
J Cell Physiol; 2008 Nov; 217(2):319-27. PubMed ID: 18506785
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.
Spinella F; Rosanò L; Del Duca M; Di Castro V; Nicotra MR; Natali PG; Bagnato A
PLoS One; 2010 Jun; 5(6):e11241. PubMed ID: 20574527
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla.
Wang Z; Zhu Q; Xia M; Li PL; Hinton SJ; Li N
Hypertension; 2010 May; 55(5):1129-36. PubMed ID: 20308610
[TBL] [Abstract][Full Text] [Related]
11. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
Loinard C; Ginouvès A; Vilar J; Cochain C; Zouggari Y; Recalde A; Duriez M; Lévy BI; Pouysségur J; Berra E; Silvestre JS
Circulation; 2009 Jul; 120(1):50-9. PubMed ID: 19546390
[TBL] [Abstract][Full Text] [Related]
13. Improved diabetic wound healing through topical silencing of p53 is associated with augmented vasculogenic mediators.
Nguyen PD; Tutela JP; Thanik VD; Knobel D; Allen RJ; Chang CC; Levine JP; Warren SM; Saadeh PB
Wound Repair Regen; 2010; 18(6):553-9. PubMed ID: 20955346
[TBL] [Abstract][Full Text] [Related]
14. [Effect of
Li XY; Wu CH; Yan YJ; Wang DH; Wang MJ; Hou ZW
Zhongguo Zhen Jiu; 2022 Nov; 42(11):1278-84. PubMed ID: 36397226
[TBL] [Abstract][Full Text] [Related]
15. Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms.
Schultz K; Murthy V; Tatro JB; Beasley D
Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L921-7. PubMed ID: 19304911
[TBL] [Abstract][Full Text] [Related]
16. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation.
Takeda K; Fong GH
Hypertension; 2007 Jan; 49(1):178-84. PubMed ID: 17101841
[TBL] [Abstract][Full Text] [Related]
17. The novel prolyl hydroxylase-2 inhibitor caffeic acid upregulates hypoxia inducible factor and protects against hypoxia.
Guo Z; Yang Y; Li L; Zhao Q; Li Y; Liu Z; Hao L; Guo B; Diao A
Eur J Pharmacol; 2022 Nov; 934():175307. PubMed ID: 36191632
[TBL] [Abstract][Full Text] [Related]
18. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression.
McMahon S; Charbonneau M; Grandmont S; Richard DE; Dubois CM
J Biol Chem; 2006 Aug; 281(34):24171-81. PubMed ID: 16815840
[TBL] [Abstract][Full Text] [Related]
20. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
